Transjugular liver biopsy is a safe and effective intervention to guide management for patients with a congenital bleeding disorder infected with hepatitis C

Internal Medicine Journal

Volumn 35, Issue 9, 2005, Pages 556-559

  Dawson, M A ^a   McCarthy, P H ^a   Walsh, M E ^a   McLean, C A ^b   Thomson, K ^b   Roberts, S ^b   Street, Alison M ^a,c  

^a Ronald Sawers Haemophilia Centre   (Australia)

^b The Alfred ^*  (Australia)

^c The Alfred   (Australia)

Author keywords

Congenital bleeding disorder; Haemophilia; Hepatitis C; Liver biopsy; Transjugular

Indexed keywords

ALPHA2A INTERFERON; BIOSTATE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN; MONOFIX; RIBAVIRIN;

ARTICLE; BLEEDING DISORDER; CONGENITAL DISORDER; CRYOPRECIPITATION; DEMOGRAPHY; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HEPATITIS C VIRUS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; INFECTIOUS HEPATITIS; LABORATORY TEST; LIVER BIOPSY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROPHYLAXIS; VON WILLEBRAND DISEASE;

ADULT; BIOPSY; BLOOD COAGULATION DISORDERS; FEMALE; HEPATITIS C; HUMANS; JUGULAR VEINS; LIVER; MALE; MIDDLE AGED; PROGNOSIS;

EID: 24744460903     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00877.x     Document Type: Article

References (19)

1. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 1990; 76: 254-6.
2. Street AM, Williams JL. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Med J Aust 1992; 157: 284.
3. Makris M, Preston FE, Rosendaal FR, Underwood JC, Rice KM, Triger DR. The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 1996; 94: 746-52.
4. Wilde JT. HIV and HCV coinfection in haemophilia. Haemophilia 2004; 10: 1-8.
5. Le Calvez S, Thabut D, Messous D, Munteanu M, Ratziu V, Imbert-Bismut F et al. The predictive value of Fibrotest versus APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology 2004; 39: 862-3; author reply 863.
6. National Institutes of Health Consensus Development Conference Panel statement. Management of hepatitis C. Hepatology 1997; 26(3 Suppl 1): 2S-10S.
7. EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus Statement. European association for the study of the liver. J Hepatol 1999; 30: 956-61.
8. Seeff LB, Hoofnagle JH. National institutes of health consensus development conference: management of hepatitis C: 2002. Hepatology 2002; 36: S1-2.
9. Aledort LM, Levine PH, Hilgartner M, Blatt P, Spero JA, Goldberg JD et al. A study of liver biopsies and liver disease among hemophiliacs. Blood 1985; 66: 367-72.
10. Lee CA. Investigation of chronic hepatitis C infection in individuals with haemophilia. Br J Haematol 1997; 96: 425-6.
11. DiMichele DM, Mirani G, Wilfredo Canchis P, Trost DW, Talal AH. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia 2003; 9: 613-18.
12. Stieltjes N, Ounnoughene N, Sava E, Paugy P, Roussel-Robert V, Rosenberg AR et al. Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus. Br J Haematol 2004; 125: 769-76.
13. McAfee JH, Keeffe EB, Lee RG, Rosch J. Transjugular liver biopsy. Hepatology 1992; 15: 726-32.
14. Lebrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy. An experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982; 83: 338-40.
15. Bedossa P, Poynard T; The METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-93.
16. Santagostino E, De Filippi F, Rumi MG, Rivi M, Colombo M, Mannucci PM. Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients. Transfusion 2004; 44: 790-4.
17. Beurton I, Bertrand MA, Bresson-Hadni S, Parquet-Gernez A, Goudemand J, Paris JC et al. Interferon alpha therapy in haemophilic patients with chronic hepatitis C. A French multicentre pilot study of 58 patients. Eur J Gastroenterol Hepatol 2001; 13: 859-64.
18. Sauleda S, Esteban JI, Altisent C, Puig L, Esteban R, Guardia J. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C. Thromb Haemost 2000; 83(5 Suppl 1): 807-10.
19. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36: S237-44.